Diaferon
Munich
About Diaferon
Diaferon is a biotechnology company developing a drug delivery system to control the release and distribution of therapeutic particles.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $927.0K
- Funding stage: Seed
- Last round: Seed (Jul 2007)
Canonical: https://fsome.com/organization/diaferon-8315126 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.